
    
      An open-label randomized, single oral dose, two way crossover bioequivalence study to compare
      ondansetron Orally Dissolving FilmStrip (ODFS) 8mg with Zofran Orally Disintegrating Tablets
      [ODTÂ® (Containing Ondansetron 8 mg)] in 48 healthy, adult, human study participants under fed
      conditions. Volunteers who signed the consent form and showed their willingness to
      participate in the study were enrolled. Volunteers who satisfied the inclusion and exclusion
      criteria and found to be healthy on physical examination with laboratory investigation values
      within reference limits were considered eligible to be admitted into the study. Study
      participants were fasted for 10 hours prior to dosing in both periods. Dosing was conducted
      as per the randomization schedule in each period under fed conditions.A washout period of 7
      days was observed between the two periods.
    
  